Corcept Therapeutics, Inc. (NASDAQ:CORT)

CAPS Rating: 2 out of 5

A pharmaceutical company which is engaged in the development of drugs for the treatment of severe psychiatric and metabolic diseases.

Recs

0
Player Avatar adamsawesome (40.04) Submitted: 1/13/2013 5:42:06 PM : Outperform Start Price: $2.00 CORT Score: -37.85

After a lot of bad luck, I think this stock is finally going to make a rally.

Featured Broker Partners


Advertisement